1. Zamboni MM, da Silva CT Jr., Baretta R, Cunha ET, Cardo- so GP. Important prognostic factors for survival in patients with malignant pleural effusion. BMC Pulm Med 2015; 15: 29.
2.
Chandra A, Crothers B, Kurtycz D, Schmitt F. Announcement: the International System for Reporting Serous Fluid Cytopathology. Acta Cytol 2019; 63: 349-351.
3.
Chandra A, Crothers B, Kurtycz D, Schmitt F. The International System for Reporting Serous Fluid Cytopathology. 1st ed. Cham: Springer, Berlin 2020.
4.
Srinivasan R, Rekhi B, Rajwanshi A, Pathuthara S, Mathur S, Jain D, et al. Indian Academy of Cytologists Guidelines for Collection, Preparation, Interpretation, and Reporting of Serous Effusion Fluid Samples. J Cytol 2020; 37: 1-11.
5.
Kundu R, Srinivasan R, Dey P, Gupta N, Gupta P, Rohilla M, et al. Application of Indian Academy of Cytologists guidelines for reporting serous effusions: an institutional experience. J Cytol 2021; 38: 1-7.
6.
Yang H, Zhu J, Wang P. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) in reporting serous effusion. A retrospective study. Medicine 2023; 102: 43.
7.
Pergaris A, Stefanou D, Keramari P, Sousouris S, Kavantzas N, Gogas H, et al. Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment. Diagnostics (Basel) 2021; 11: 2223.
8.
Straccia P, Chiappetta M, Magnini D, Cancellieri A. Application of the International System for Reporting Serous Fluid Cytopathology (TIS): a retrospective institutional study. Cytopathology 2022; 33: 305-311.
9.
Rooper LM, Ali SZ, Olson MT. A minimum fluid volume of 75 ml is needed to ensure adequacy in a pleural effusion: a retrospective analysis of 2540 cases. Cancer Cytopathol 2014; 122: 657-665.
10.
Pinto D, Cruz E, Branco D, Linares C, Carvalho C, Silva A, et al. Cytohistological correlation in pleural effusions based on the International System for Reporting Serous Fluid Cytopathology. Diagnostics (Basel) 2021; 11: 1126.
11.
Lobo C, Costa J, Petronilho S, Monteiro P, Leça L, Schmitt F. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center. Diagn Cytopathol 2021; 49: 596-605.
12.
Rakheja G, Singh M, Priyadarshnee B, Marimuthu B, Dhar L, Jain S, et al. Categorisation of peritoneal serous effusions using the International System for Reporting Serous Fluid Cytopathology – a study on gynaecological samples. Cytopathology 2023; 34: 138-145.
13.
Rajeswaran PK, Srinivasan V, Mahesh SSV, Ashok AU. A retrospective analysis of the application of the newly proposed International System for Reporting Serous Fluid Cytopathology on serous effusion specimens: an institutional experience. Acta Cytologica 2023; 67: 70‑79.
14.
Song MJ, Jo U, Jeong JS, Cho KJ, Gong G, Cho YM, et al. Clinico-cytopathologic analysis of 574 pericardial effusion specimens: application of the international system for reporting serous fluid cytopathology (ISRSFC) and long-term clinical follow-up. Cancer Med 2021; 10: 8899-908.
15.
Wang M, Sun T, Jiao J, Wang H. Application of the International System for Reporting Serous Fluid Cytopathology to pericardial fluid: root-cause analysis of indeterminate diagnoses, cyto-histological correlation, and assessment of risk of malignancy. Cancer Cytopathol 2023; 131: 433-441.
16.
Da Silva DJC, Dos Santos CR, Xavier-Júnior JCC. Risk of Malignancy in Effusions according to the International System for Serous Fluid Cytopathology: a review. Acta Cytol 2024; 68: 384-393.
17.
Zhu YL, Ren WH, Wang Q, Jin HZ, Guo YY, Lin DM. A retrospective analysis of serous effusions based on the newly proposed international system for reporting serous fluid cytopathology: a report of 3633 cases in an oncological center. Diagn Path 2022; 17: 56.
18.
Sharma S, Mohapatra DS, Gupta N, Srinivasan R, Rajwanshi A, Dey P. Cytology of peritoneal implants of borderline serous tumor of ovaries in ascitic fluid. Cytojournal 2021; 18: 17.
19.
Lu CH, Liu CY, Jhuang JY, Chen CC. Comprehensive evaluation of benign and malignant etiologies of different serous effusions with the International System for Reporting Serous Fluid Cytopathology: a multi-institutional study in Taiwan. Cancer Cytopathol 2024; 132: 169-178.
20.
Lim KH, Ahmed SS, Cheng XM, Hwang JSG, Karunanithi J, Mantoo S et al. A single tertiary institution review of the International System for Serous Fluid Cytopathology and the impact of cell block and ancillary studies on its performance. J Am Soc Cytopathol 2023; 12: 48-57.